Published in Br J Cancer on September 25, 2007
Regulation of superoxide dismutase genes: implications in disease. Free Radic Biol Med (2009) 2.35
Epigenetic attenuation of mitochondrial superoxide dismutase 2 in pulmonary arterial hypertension: a basis for excessive cell proliferation and a new therapeutic target. Circulation (2010) 2.06
Superoxide dismutase downregulation in osteoarthritis progression and end-stage disease. Ann Rheum Dis (2010) 1.25
Epigenetic silencing of SOD2 by histone modifications in human breast cancer cells. Free Radic Biol Med (2008) 1.20
A review of pterostilbene antioxidant activity and disease modification. Oxid Med Cell Longev (2013) 1.09
Fraternal twins: Swiprosin-1/EFhd2 and Swiprosin-2/EFhd1, two homologous EF-hand containing calcium binding adaptor proteins with distinct functions. Cell Commun Signal (2011) 1.09
Manganese superoxide dismutase: beyond life and death. Amino Acids (2010) 1.06
MnSOD in oxidative stress response-potential regulation via mitochondrial protein influx. Antioxid Redox Signal (2013) 1.04
Epigenetic regulation of Keap1-Nrf2 signaling. Free Radic Biol Med (2015) 0.97
Epigenetic mechanisms of pulmonary hypertension. Pulm Circ (2011) 0.93
Regulation of SOD2 in cancer by histone modifications and CpG methylation: closing the loop between redox biology and epigenetics. Antioxid Redox Signal (2012) 0.90
Acquisition of resistance of pancreatic cancer cells to 2-methoxyestradiol is associated with the upregulation of manganese superoxide dismutase. Mol Cancer Res (2012) 0.87
Genomic analysis of pterostilbene predicts its antiproliferative effects against pancreatic cancer in vitro and in vivo. J Gastrointest Surg (2012) 0.80
Oxygen in human health from life to death - An approach to teaching redox biology and signaling to graduate and medical students. Redox Biol (2015) 0.79
Genetic oxidative stress variants and glioma risk in a Chinese population: a hospital-based case-control study. BMC Cancer (2012) 0.79
Up-regulation of mitochondrial antioxidation signals in ovarian cancer cells with aggressive biologic behavior. J Zhejiang Univ Sci B (2011) 0.77
Histone deacetylation contributes to low extracellular superoxide dismutase expression in human idiopathic pulmonary arterial hypertension. Am J Physiol Lung Cell Mol Physiol (2016) 0.77
The emerging role of epigenetics in pulmonary arterial hypertension: an important avenue for clinical trials (2015 Grover Conference Series). Pulm Circ (2016) 0.76
Biochemical and molecular modulation of CCl4-induced peripheral and central damage by Tilia americana var. mexicanaextracts. Saudi Pharm J (2016) 0.75
Epigenetic Regulation of Redox Signaling in Diabetic Retinopathy: Role of Nrf2. Free Radic Biol Med (2016) 0.75
Superoxide Dismutases in Pancreatic Cancer. Antioxidants (Basel) (2017) 0.75
Stable suppression of tumorigenicity by virus-mediated RNA interference. Cancer Cell (2002) 7.88
Radical causes of cancer. Nat Rev Cancer (2003) 5.45
Reverse phase protein microarrays which capture disease progression show activation of pro-survival pathways at the cancer invasion front. Oncogene (2001) 4.40
Life-long reduction in MnSOD activity results in increased DNA damage and higher incidence of cancer but does not accelerate aging. Physiol Genomics (2003) 3.84
Biochemistry of oxygen toxicity. Annu Rev Biochem (1989) 3.26
Molecular alterations in primary prostate cancer after androgen ablation therapy. Clin Cancer Res (2005) 1.88
Zebularine: a novel DNA methylation inhibitor that forms a covalent complex with DNA methyltransferases. J Mol Biol (2002) 1.61
GSTP1 CpG island hypermethylation is responsible for the absence of GSTP1 expression in human prostate cancer cells. Am J Pathol (2001) 1.60
The role of manganese superoxide dismutase in the growth of pancreatic adenocarcinoma. Cancer Res (2003) 1.58
Overexpression of manganese superoxide dismutase suppresses tumor formation by modulation of activator protein-1 signaling in a multistage skin carcinogenesis model. Cancer Res (2001) 1.48
Suppression of the malignant phenotype in human pancreatic cancer cells by the overexpression of manganese superoxide dismutase. Mol Cancer Ther (2003) 1.45
Mutations in the promoter reveal a cause for the reduced expression of the human manganese superoxide dismutase gene in cancer cells. Oncogene (1999) 1.36
Manganese superoxide dismutase overexpression inhibits the growth of androgen-independent prostate cancer cells. Oncogene (2005) 1.30
Cross-talk between calcium and reactive oxygen species signaling. Acta Pharmacol Sin (2006) 1.27
Suppression of the malignant phenotype of human glioma cells by overexpression of manganese superoxide dismutase. Oncogene (1997) 1.25
Inhibition of cell growth by overexpression of manganese superoxide dismutase (MnSOD) in human pancreatic carcinoma. Free Radic Res (2004) 1.25
Mitochondrial oxidative stress. Physiologic consequences and potential for a role in aging. Ann N Y Acad Sci (2000) 1.18
Mechanisms of endothelial response to oxidative aggression: protective role of autologous VEGF and induction of VEGFR2 by H2O2. Am J Physiol Heart Circ Physiol (2006) 1.12
Transfection and expression of MnSOD cDNA decreases tumor malignancy of human oral squamous carcinoma SCC-25 cells. Hum Gene Ther (1997) 1.09
Overexpression of manganese superoxide dismutase in DU145 human prostate carcinoma cells has multiple effects on cell phenotype. Prostate (1998) 1.08
MnSOD expression is less frequent in tumour cells of invasive breast carcinomas than in in situ carcinomas or non-neoplastic breast epithelial cells. J Pathol (2001) 1.05
The molecular pathogenesis of prostate cancer: Implications for prostate cancer prevention. Urology (2001) 1.05
Overexpression of manganese superoxide dismutase selectively modulates the activity of Jun-associated transcription factors in fibrosarcoma cells. Cancer Res (1997) 1.05
Potent antitumor activity of 2-methoxyestradiol in human pancreatic cancer cell lines. Clin Cancer Res (1999) 1.03
Redox regulation of pancreatic cancer cell growth: role of glutathione peroxidase in the suppression of the malignant phenotype. Hum Gene Ther (2004) 1.01
Enforced expression of superoxide dismutase 2/manganese superoxide dismutase disrupts autocrine interleukin-6 stimulation in human multiple myeloma cells and enhances dexamethasone-induced apoptosis. Cancer Res (2005) 0.99
Epigenetic silencing of manganese superoxide dismutase (SOD-2) in KAS 6/1 human multiple myeloma cells increases cell proliferation. Cancer Biol Ther (2005) 0.98
2-Methoxyestradiol induces mitochondria dependent apoptotic signaling in pancreatic cancer cells. Oncogene (2002) 0.93
Alteration of cellular phenotype and responses to oxidative stress by manganese superoxide dismutase and a superoxide dismutase mimic in RWPE-2 human prostate adenocarcinoma cells. Antioxid Redox Signal (2004) 0.92
Superoxide-dependent and -independent mitochondrial signaling during apoptosis in multiple myeloma cells. Oncogene (2003) 0.90
Maspin gene expression in tumor suppression induced by overexpressing manganese-containing superoxide dismutase cDNA in human breast cancer cells. Carcinogenesis (1998) 0.88
Antitumor properties of 2(1H)-pyrimidinone riboside (zebularine) and its fluorinated analogues. J Med Chem (1991) 0.87
Superoxide dismutase is induced during rat pancreatic acinar cell injury. Pancreas (2002) 0.84
Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia. N Engl J Med (2001) 24.51
Attitudes and beliefs of African Americans toward participation in medical research. J Gen Intern Med (1999) 11.58
Thymoma production of T cell growth factor (Interleukin 2). J Immunol (1980) 5.58
African Americans' views on research and the Tuskegee Syphilis Study. Soc Sci Med (2001) 5.23
The biochemistry, biology, and role of interleukin 2 in the induction of cytotoxic T cell and antibody-forming B cell responses. Immunol Rev (1982) 4.43
Regulation of the production of immune interferon and cytotoxic T lymphocytes by interleukin 2. J Immunol (1981) 4.04
CD44+ CD24(-) prostate cells are early cancer progenitor/stem cells that provide a model for patients with poor prognosis. Br J Cancer (2008) 2.58
Targeted deletion of the Vgf gene indicates that the encoded secretory peptide precursor plays a novel role in the regulation of energy balance. Neuron (1999) 2.15
Human immunodeficiency virus glycoprotein (gp120) induction of monocyte arachidonic acid metabolites and interleukin 1. Proc Natl Acad Sci U S A (1989) 2.02
Interleukin-2 stimulates association of protein kinase C with plasma membrane. Nature (1985) 1.96
Macrophage-independent activation of helper T cells. I. Production of Interleukin 2. J Immunol (1980) 1.96
Upregulation of vascular endothelial growth factor in ischemic and non-ischemic human and experimental retinal disease. Histol Histopathol (1997) 1.90
Specific inhibition of c-myc protein biosynthesis using an antisense synthetic deoxy-oligonucleotide in human T lymphocytes. J Immunol (1988) 1.86
Interleukin 6 activates androgen receptor-mediated gene expression through a signal transducer and activator of transcription 3-dependent pathway in LNCaP prostate cancer cells. Cancer Res (2000) 1.86
Activation of human T lymphocytes is inhibited by peroxisome proliferator-activated receptor gamma (PPARgamma) agonists. PPARgamma co-association with transcription factor NFAT. J Biol Chem (2000) 1.82
Establishment of continuous cultures of thy1.2+, Lyt1+, 2-T cells with purified interleukin 3. Cell (1981) 1.80
Participation of lymphocyte activating factor (Interleukin 1) in the induction of cytotoxic T cell responses. J Immunol (1980) 1.72
Tuskegee: from science to conspiracy to metaphor. Am J Med Sci (1999) 1.64
Phorbol myristic acetate enhances the production of interleukin 2. Cell Immunol (1981) 1.54
The effect of a bi-annual professional application of APF foam on dental caries increment in primary teeth: 24-month clinical trial. J Dent Res (2005) 1.53
The HIV-1 gp120 envelope protein has the intrinsic capacity to stimulate monokine secretion. J Immunol (1991) 1.51
Activation of receptor-associated tyrosine kinase JAK2 by prolactin. J Biol Chem (1994) 1.46
The role of a gamma interferon-like lymphokine in the activation of T cells for expression of interleukin 2 receptors. Cell Immunol (1983) 1.46
Significance of perihematomal edema in acute intracerebral hemorrhage: the INTERACT trial. Neurology (2009) 1.44
Octapeptides deduced from the neuropeptide receptor-like pattern of antigen T4 in brain potently inhibit human immunodeficiency virus receptor binding and T-cell infectivity. Proc Natl Acad Sci U S A (1986) 1.43
JAK2 activation and cell proliferation induced by antibody-mediated prolactin receptor dimerization. Endocrinology (1994) 1.40
Altered cytosol/membrane enzyme redistribution on interleukin-3 activation of protein kinase C. Nature (1985) 1.39
Analysis of effector mechanisms against HTLV-I- and HTLV-III/LAV-infected lymphoid cells. J Immunol (1986) 1.37
Prolactin receptor triggering. Evidence for rapid tyrosine kinase activation. J Biol Chem (1992) 1.35
Tissue expansion: dividend or loan? Plast Reconstr Surg (1986) 1.35
HIV-1 and its envelope glycoprotein down-regulate chemotactic ligand receptors and chemotactic function of peripheral blood monocytes. J Immunol (1989) 1.34
IL-2 regulation of tyrosine kinase activity is mediated through the p70-75 beta-subunit of the IL-2 receptor. J Immunol (1989) 1.33
Interleukin 2 regulates immune interferon (IFN gamma) production by normal and suppressor cell cultures. J Immunol (1982) 1.32
Interleukin-6 regulation of the human DNA methyltransferase (HDNMT) gene in human erythroleukemia cells. J Biol Chem (2001) 1.31
Mitogen and lymphokine stimulation of heat shock proteins in T lymphocytes. Proc Natl Acad Sci U S A (1988) 1.31
Differential control of the phosphorylation state of proline-juxtaposed serine residues Ser725 of Stat5a and Ser730 of Stat5b in prolactin-sensitive cells. J Biol Chem (1998) 1.31
Visualization and characterization of interleukin 1 receptors in brain. J Immunol (1987) 1.30
First observation of the Greisen-Zatsepin-Kuzmin suppression. Phys Rev Lett (2008) 1.29
Blood-retinal barrier (BRB) breakdown in experimental autoimmune uveoretinitis: comparison with vascular endothelial growth factor, tumor necrosis factor alpha, and interleukin-1beta-mediated breakdown. J Neurosci Res (1997) 1.29
JAK3, STAT, and MAPK signaling pathways as novel molecular targets for the tyrphostin AG-490 regulation of IL-2-mediated T cell response. J Immunol (1999) 1.27
Metabolism and disposition of the HIV-1 protease inhibitor ritonavir (ABT-538) in rats, dogs, and humans. Drug Metab Dispos (1997) 1.24
Growth signaling and JAK2 association mediated by membrane-proximal cytoplasmic regions of prolactin receptors. J Biol Chem (1994) 1.17
Population pharmacokinetics of imatinib mesylate in patients with chronic-phase chronic myeloid leukaemia: results of a phase III study. Br J Clin Pharmacol (2005) 1.15
The role of arachidonic acid metabolism in the activities of interleukin 1 and 2. J Immunol (1985) 1.13
Effects of imatinib mesylate (STI571, Glivec) on the pharmacokinetics of simvastatin, a cytochrome p450 3A4 substrate, in patients with chronic myeloid leukaemia. Br J Cancer (2003) 1.12
Characterization of liposome-mediated gene delivery: expression, stability and pharmacokinetics of plasmid DNA. Gene Ther (1997) 1.12
Nitric oxide and thiol redox regulation of Janus kinase activity. Proc Natl Acad Sci U S A (1998) 1.11
Association of protein kinase C activation with IL 2 receptor expression. J Immunol (1986) 1.11
Prolactin recruits STAT1, STAT3 and STAT5 independent of conserved receptor tyrosines TYR402, TYR479, TYR515 and TYR580. Mol Cell Endocrinol (1996) 1.11
Epigenetic gene regulation in stem cells and correlation to cancer. Differentiation (2009) 1.11
Interleukin 2 induction of interferon-gamma mRNA synthesis. J Immunol (1986) 1.09
Ex vivo cytotoxicity of a new calcium silicate-based canal filling material. Int Endod J (2010) 1.07
Knowledge about AIDS and reported risk behaviors among black college students. J Am Coll Health (1989) 1.07
Interleukin 2 regulation of mitogen induction of immune interferon (IFN gamma) in spleen cells and thymocytes. Cell Immunol (1982) 1.06
Activation of estrogen receptor blocks interleukin-6-inducible cell growth of human multiple myeloma involving molecular cross-talk between estrogen receptor and STAT3 mediated by co-regulator PIAS3. J Biol Chem (2001) 1.05
Endotoxin induced uveitis in the mouse: susceptibility and genetic control. Exp Eye Res (1995) 1.05
Meta- and pooled analyses of the methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism and colorectal cancer: a HuGE-GSEC review. Am J Epidemiol (2009) 1.05
Inducible upregulation of oestrogen receptor-beta1 affects oestrogen and tamoxifen responsiveness in MCF7 human breast cancer cells. J Mol Endocrinol (2005) 1.04
Tyrphostin AG-490 inhibits cytokine-mediated JAK3/STAT5a/b signal transduction and cellular proliferation of antigen-activated human T cells. J Leukoc Biol (1999) 1.04
Targeted disruption of stat6 DNA binding activity by an oligonucleotide decoy blocks IL-4-driven T(H)2 cell response. Blood (2000) 1.03
Altered processing of pro-orphanin FQ/nociceptin and pro-opiomelanocortin-derived peptides in the brains of mice expressing defective prohormone convertase 2. J Neurosci (2001) 1.03
Appendico-vesical fistula. J Urol (1969) 1.02
Interleukin-2 induces tyrosine phosphorylation of the vav proto-oncogene product in human T cells: lack of requirement for the tyrosine kinase lck. Biochem J (1993) 1.02
An EZH2 polymorphism is associated with clinical outcome in metastatic colorectal cancer patients. Ann Oncol (2011) 1.00
Mortality in 7B2 null mice can be rescued by adrenalectomy: involvement of dopamine in ACTH hypersecretion. Proc Natl Acad Sci U S A (2002) 1.00
Regulation of expression of the interleukin-2 receptor on hematopoietic cells by interleukin-3. Science (1986) 0.99
Expression of transfected human interferon-gamma DNA: evidence for cell-specific regulation. J Immunol (1986) 0.99
Macrophages as effector cells of protective immunity in murine schistosomiasis: macrophage activation in mice vaccinated with radiation-attenuated cercariae. Infect Immun (1984) 0.98
Prolactin stimulates serine/tyrosine phosphorylation and formation of heterocomplexes of multiple Stat5 isoforms in Nb2 lymphocytes. J Biol Chem (1997) 0.98
Potential role of estrogen receptor alpha (ERalpha) phosphorylated at Serine118 in human breast cancer in vivo. J Steroid Biochem Mol Biol (2006) 0.96
William Appleton Cuthbert 1912-1966. J Appl Bacteriol (1966) 0.96
The aggressive form of cherubism: report of two cases in unrelated families. Br J Oral Maxillofac Surg (2005) 0.95
Effects of anti-proliferative cyclic AMP on interleukin 2-stimulated gene expression. J Immunol (1987) 0.95
Inhibition of adenylate cyclase by IL 2 in human T lymphocytes is mediated by protein kinase C. Biochem Biophys Res Commun (1987) 0.95
Characterization of active and inactive forms of the JAK2 protein-tyrosine kinase produced via the baculovirus expression vector system. J Biol Chem (1995) 0.95
Characterization of a 97-kDa phosphotyrosylprotein regulated by multiple cytokines. J Biol Chem (1992) 0.95
Suppressor cell activity in tumor-bearing mice. I. Dualistic inhibition by suppressor T lymphocytes and macrophages. J Immunol (1978) 0.95
Functional uncoupling of the Janus kinase 3-Stat5 pathway in malignant growth of human T cell leukemia virus type 1-transformed human T cells. J Immunol (2000) 0.95
Interleukin 2 and diacylglycerol stimulate phosphorylation of 40 S ribosomal S6 protein. Correlation with increased protein synthesis and S6 kinase activation. J Biol Chem (1987) 0.95
Activation of JAK3, but not JAK1, is critical for IL-2-induced proliferation and STAT5 recruitment by a COOH-terminal region of the IL-2 receptor beta-chain. Cytokine (1995) 0.95
Association of the erythropoietin receptor with protein tyrosine kinase activity. Proc Natl Acad Sci U S A (1992) 0.94
In vitro metabolism of terfenadine by a purified recombinant fusion protein containing cytochrome P4503A4 and NADPH-P450 reductase. Comparison to human liver microsomes and precision-cut liver tissue slices. Drug Metab Dispos (1995) 0.94
The phospholipid-dependence of uridine diphosphate glucuronyltransferase. Phospholipid depletion and re-activation of guinea-pig liver microsomal enzyme. Biochem J (1977) 0.94
Stimulation of specific GTP binding and hydrolysis activities in lymphocyte membrane by interleukin-2. Nature (1987) 0.94
Experiences from a school-based oral health promotion programme in Wuhan City, PR China. Int J Paediatr Dent (2001) 0.94
Defects in ProTaper S1 instruments after clinical use: fractographic examination. Int Endod J (2005) 0.93
Biochemical and molecular events associated with interleukin 2 regulation of lymphocyte proliferation. Immunol Rev (1986) 0.93
Signal transduction of human interleukin 3 and granulocyte-macrophage colony-stimulating factor through serine and tyrosine phosphorylation. Biochem J (1990) 0.93
A quantitative (stereological) study of the effects of experimental unilateral cryptorchidism and subsequent orchiopexy on spermatogenesis in adult rabbit testis. Reproduction (2002) 0.93
An ecological study of the psychrotrophic bacteria of soil, water, grass and hay. J Appl Bacteriol (1970) 0.92
Role of c-myc and other genes in interleukin 2 regulated CT6 T lymphocytes and their malignant variants. J Immunol (1987) 0.92
Prolactin activates Ras via signaling proteins SHC, growth factor receptor bound 2, and son of sevenless. Endocrinology (1995) 0.92
In situ detection of a heat-shock regulatory element binding protein using a soluble synthetic enhancer sequence. Nucleic Acids Res (1989) 0.92
IFN-gamma inhibits c-myc gene expression by impairing the splicing process in a colony-stimulating factor dependent murine myeloid cell line. J Immunol (1988) 0.91
Pharmacokinetically guided dosing of carboplatin and etoposide during peritoneal dialysis and haemodialysis. Br J Cancer (1996) 0.91
Activation of JAK3, but not JAK1, is critical to interleukin-4 (IL4) stimulated proliferation and requires a membrane-proximal region of IL4 receptor alpha. J Biol Chem (1995) 0.91
A novel locus for autosomal dominant hereditary gingival fibromatosis, GINGF3, maps to chromosome 2p22.3-p23.3. Clin Genet (2005) 0.90
Regulation of the interleukin 2 receptor complex tyrosine kinase activity in vitro. Cytokine (1991) 0.90
Interleukin-13 is a potent activator of JAK3 and STAT6 in cells expressing interleukin-2 receptor-gamma and interleukin-4 receptor-alpha. Biochem J (1996) 0.89